vSpring Capital

vSpring Capital, a private equity and venture capital firm founded in 2000 and based in Salt Lake City, Utah, specialized in seed, startup, and early-stage investments, as well as selective later-stage investments. The firm focused primarily on information technology and life sciences sectors, particularly in the Intermountain West region of the United States, with an emphasis on areas such as enterprise software, networking, communications, security software, drug discovery, and medical devices. vSpring Capital aimed to invest between $250,000 and $5 million, often taking on the role of lead investor and securing a board seat in portfolio companies. The firm was known for its labor-intensive, service-oriented approach, providing operational assistance to enhance value, facilitate introductions to key partners, and aid in executive recruitment. In 2012, vSpring Capital was acquired by Signal Peak Ventures, after which both firms operated under the Signal Peak Ventures name.

Ed Ekstrom

Managing Director

Past deals in Albuquerque, NM

nanoMR

Series B in 2011
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.

nanoMR

Series A in 2008
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.

VeraLight

Series C in 2008
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS® system. Their mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.

Aspen Avionics

Series B in 2007
Aspen Avionics, based in Albuquerque, New Mexico, was founded by aviation enthusiasts in 2004. The company specializes in bringing the most advanced technology and capability into general aviation cockpits. Its products increase situational awareness and reduce pilot workload, making it even easier and safer to fly in both VFR and IFR conditions. The company’s philosophy is that getting the latest avionics technology shouldn’t always mean spending a lot of money—on equipment or on installation.

VeraLight

Series B in 2006
VeraLight is a medical device company that was established in October 2004 to focus on a comprehensive approach to non-invasive type 2 diabetes and pre-diabetes screening with the proprietary SCOUT DS® system. Their mission is to help stem the tide of the worldwide diabetes epidemic by driving early diabetes detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications. The company develops and acquires intellectual property, products, and services that contribute to this mission.

Aspen Avionics

Series A in 2005
Aspen Avionics, based in Albuquerque, New Mexico, was founded by aviation enthusiasts in 2004. The company specializes in bringing the most advanced technology and capability into general aviation cockpits. Its products increase situational awareness and reduce pilot workload, making it even easier and safer to fly in both VFR and IFR conditions. The company’s philosophy is that getting the latest avionics technology shouldn’t always mean spending a lot of money—on equipment or on installation.